...
首页> 外文期刊>Journal of chemotherapy >Activity of ceftaroline and comparator agents tested against contemporary Gram-positive and -negative (2011) isolates collected in Europe, Turkey, and Israel
【24h】

Activity of ceftaroline and comparator agents tested against contemporary Gram-positive and -negative (2011) isolates collected in Europe, Turkey, and Israel

机译:头孢洛林和比较剂对欧洲,土耳其和以色列的当代革兰氏阳性和阴性(2011年)分离株的活性进行了测试

获取原文
获取原文并翻译 | 示例
           

摘要

The activity of ceftaroline was tested against 8233 isolates mainly collected from bloodstream, urinary, respiratory and skin and soft tissue specimens in European medical centers during 2011. This cephalosporin displayed activity against Staphylococcus aureus (MIC50, 0.25 mg/l), with greater activity against MRSA (MIC50, 1 mg/l) than other β-lactams tested. Against Streptococcus pneumoniae, including penicillin-resistant strains, other streptococcal groups and Haemophilus spp., ceftaroline was highly active and MIC90 values ranged from ≤0.015 to 0.12 mg/l. Ceftaroline, like other cephalosporins, had limited activity against ESBL-phenotype Enterobacteriaceae, but showed good activity against isolates not displaying an ESBL-phenotype. Ceftaroline remains very active against MRSA and other organisms than could be associated with its approved indications in the EU (complicated skin and soft tissue infections and community-acquired pneumonia).
机译:在2011年期间,测试了头孢洛林对8233株分离物的活性,这些分离物主要是从欧洲医学中心的血流,泌尿,呼吸系统,皮肤和软组织标本中采集的。该头孢菌素具有抗金黄色葡萄球菌的活性(MIC50,0.25 mg / l),对头孢菌素的活性更高MRSA(MIC50,1 mg / l)比其他β-内酰胺测试。头孢洛林对肺炎链球菌(包括耐青霉素的菌株,其他链球菌和嗜血杆菌属)具有很高的活性,MIC90值在≤0.015至0.12 mg / l的范围内。头孢洛林与其他头孢菌素一样,对ESBL表型肠杆菌科的活性有限,但对不显示ESBL表型的分离株表现出良好的活性。头孢洛林对MRSA和其他生物仍然非常活跃,与其在欧盟已批准的适应症(复杂的皮肤和软组织感染以及社区获得性肺炎)相比可能具有很高的活性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号